company background image
MKKG.Y logo

Merck KGaA OTCPK:MKKG.Y Stock Report

Last Price

US$34.73

Market Cap

US$75.4b

7D

1.3%

1Y

-5.2%

Updated

27 Mar, 2024

Data

Company Financials +

MKKG.Y Stock Overview

Merck KGaA operates as a science and technology company in Germany.

MKKG.Y fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends4/6

Rewards

Risk Analysis

No risks detected for MKKG.Y from our risk checks.

Merck KGaA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Merck KGaA
Historical stock prices
Current Share Price€34.73
52 Week High€38.63
52 Week Low€28.59
Beta0.66
1 Month Change2.09%
3 Month Change10.15%
1 Year Change-5.24%
3 Year Change1.70%
5 Year Change52.32%
Change since IPO187.98%

Recent News & Updates

Recent updates

Shareholder Returns

MKKG.YUS PharmaceuticalsUS Market
7D1.3%1.2%0.4%
1Y-5.2%25.8%28.8%

Return vs Industry: MKKG.Y underperformed the US Pharmaceuticals industry which returned 23.9% over the past year.

Return vs Market: MKKG.Y underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is MKKG.Y's price volatile compared to industry and market?
MKKG.Y volatility
MKKG.Y Average Weekly Movement3.0%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: MKKG.Y has not had significant price volatility in the past 3 months.

Volatility Over Time: MKKG.Y's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
166862,908Belen Garijo Lopezhttps://www.emdgroup.com

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Merck KGaA Fundamentals Summary

How do Merck KGaA's earnings and revenue compare to its market cap?
MKKG.Y fundamental statistics
Market capUS$75.40b
Earnings (TTM)US$3.06b
Revenue (TTM)US$22.73b

24.7x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MKKG.Y income statement (TTM)
Revenue€20.99b
Cost of Revenue€8.56b
Gross Profit€12.44b
Other Expenses€9.61b
Earnings€2.82b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 15, 2024

Earnings per share (EPS)6.50
Gross Margin59.23%
Net Profit Margin13.45%
Debt/Equity Ratio35.2%

How did MKKG.Y perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

34%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.